Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, announced today that at the annual general meeting of shareholders held earlier today …
StreetInsider · 6/18/2015
The stock market was up and down all day on Wednesday. It is volatile and tradable, but a tough market. Let’s take a look at some of the stocks that are still doing well, or did well on Wednesday. A10 Networks Inc. (NYSE:ATEN) is one of our swing trades. · 8/13/2015
The following stocks are peaking at new 52-week highs on July 15, 2015: ZGNX, RCPT, REPH, APPF, M, CELG, IDI Receptos Inc. (RCPT) has posted a new high of 230.10 above a previous 52 week high of 207.61. The company traded at $229.47 + 22.29 …
Fx Pips · 7/16/2015
The agency said it approved the Zogenix (NASDAQ:ZGNX, Stock Forum) pill Zohydro for patients with pain that requires, daily, around-the-clock treatment that cannot be addressed with other drugs. The approval comes as a surprise since the agency's own …
Stockhouse · 10/26/2013
Oct 28, 2013 (ACCESSWIRE via COMTEX) -- New York, NY - (ACCESSWIRE) - 10/28/2013 - Equity Profile Report initiates its Health-care Active Stock Watch List adding Synta Pharmaceuticals Corp. SNTA, -5.15% Dendreon Corp. DNDN Zogenix, Inc.
Market Watch · 10/28/2013
While DSW Inc. (DSW) Stock Remains In Red, Company Announces Opening Of New Stores PUBLISHED: Aug 29, 2015 at 10:33 am EST DSW Inc stock has been closing in red during the week. However, the company has announced the opening of new … · 8/29/2015
Shares of Zogenix (NASDAQ:ZGNX) have earned an average rating of “Buy” from the seven brokerages that are currently covering the company, Market Beat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have … · 7/6/2015
The reverse stock split will not affect any shareholder's ownership percentage of Zogenix's common shares. The common shares will trade under a new CUSIP number, 98978L 204, effective July 1, 2015. Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical …
GlobeNewswire · 6/18/2015
The stock closed Wednesday at $17.22. Zogenix Inc. (NASDAQ: ZGNX) presented at the conference, and it was one of our top biotechnology stocks trading under $5. The company reported it is ready to launch its newly approved pain drug Zohydro next month.
24/7 Wall ST · 2/13/2014
The position of Zogenix, Inc. (NASDAQ:ZGNX), in the equity portfolio of Jacob Gottlieb ... Visium’s stake is passive by nature and amasses 6.4% of the company’s common stock. At the current stock price of Zogenix, the value of the holding amounts ...
INSIDER MONKEY · 11/29/2013